A standard blood test done before marriage found a complicated and mostly hidden hereditary risk in a 30-year-old Indian man. This raises bigger questions about how many people may have blood problems that go undiscovered even when their tests come back "normal."

The case reported in the Indian Journal of Case Reports published an article about a patient who looked healthy during routine screenings but later turned out to have a combination of the beta-thalassaemia trait, iron deficiency anaemia, and a rare Indian blood variant called HbQ India.

The man, who has epilepsy and has been on long-term anti-seizure medication, visited a diagnostic laboratory for routine monitoring. He had mild pallor and a history of anaemia but no serious symptoms. His haemoglobin level stood at 13.5 grams per decilitre, a figure that would usually reassure both patient and doctor.

However, because he had recently married, doctors advised additional screening for inherited blood disorders. That decision proved crucial.

Through advanced testing with high-performance liquid chromatography, the researchers found that the patient had an unusual haemoglobin peak that pointed to HbQ India, an uncommon variety that is mostly prevalent in the Indian subcontinent. Upon additional examination, the researchers discovered that the patient was a carrier of beta-thalassemia, a genetic disorder that influences the formation of red blood cells.

What made the diagnosis particularly challenging was iron deficiency, one of India’s most common nutritional problems. Iron deficiency can “mask” beta-thalassaemia by keeping certain blood markers within the normal range. In this case, a key indicator called HbA2, which usually rises in thalassaemia carriers, appeared normal.

The study authors note that this masking effect means many Indians could be silent carriers of thalassaemia without knowing it. For families planning children, this has serious implications, as two carriers can pass on severe disease to their offspring.

Doctors were alerted by a simple calculation known as the Mentzer Index, which divides the size of red blood cells by their number. The patient’s result, 11.9, raised suspicion of thalassaemia despite otherwise reassuring figures. “It was the maths, not the headline numbers, that raised the red flag,” the report indicates.

The patient’s epilepsy added another layer of complexity. He had been taking phenytoin and sodium valproate for around ten months, medicines known to lower platelet counts. His reduced platelets could easily have been blamed on these drugs alone. Instead, further investigation revealed an underlying genetic explanation that medication side effects might have obscured.

HbQ India itself is usually silent and causes little or no illness. First identified in Sindhi families in the 1970s, it often goes unnoticed unless specific testing is done. Routine blood tests can't always find it, and even standard electrophoresis might not be able to tell the difference between the variation and another one.

Researchers pointed out that the difference between a regular complete blood count and HPLC is like judging a book by its cover instead of reading its chapters. A CBC gives a general picture, whereas HPLC looks at the many forms of haemoglobin that are present, which can show hidden problems.

The case underlines a broader public health message. In a country where inherited blood disorders are common, normal haemoglobin levels do not always mean healthy blood. Pre-marital or pre-conception screening, the authors argue, should be seen as a necessity rather than an optional extra.

As the report concludes, relying solely on basic tests risks missing conditions that matter not just to individuals but to future generations.